In 2024, Bumrungrad International Hospital has continued to set new benchmarks in healthcare, strengthening its legacy of excellence and innovation. This year has been marked by significant achievements and strategic initiatives, reaffirming Bumrungrad’s position as a global leader in healthcare and resonating deeply with our shareholders, physicians, management, and staff.
Our unwavering focus on delivering exceptional medical services has driven remarkable growth, as both Thai and international patients continue to choose Bumrungrad as their trusted healthcare provider. This trust highlights our steadfast commitment to quality, safety, and patient-centric care—values that are central to our operations. Through our dedication to achieving positive treatment outcomes, we have consistently enhanced lives, providing tangible benefits to patients and their families.
A defining highlight of the year was the expansion of our presence in Thailand with the opening of our first domestic campus in Phuket, encompassing Bumrungrad International Hospital and the VitalLife Scientific Wellness Center. Known as the Pearl of the Andaman, Phuket offers immense potential as a hub for both tourism and healthcare. This strategic move aligns with our vision of bringing world-class healthcare closer to communities while enhancing our leadership in the growing medical tourism market.
Bumrungrad’s excellence was further validated by an impressive array of accolades in 2024. We were honored as Thailand’s Best Hospital by Newsweek for the fourth consecutive year and remained the only Thai hospital among the World’s Best Hospitals, ranking in the top 250 globally. Additionally, Bumrungrad earned recognition as one of the World’s Best Smart Hospitals 2024 and was celebrated as one of the Best Specialized Hospitals in Asia-Pacific, excelling in key disciplines such as Cardiology, Neurology, Oncology, and Pediatrics. Notably, our Gastrointestinal Endoscopy Unit became the first in Thailand and Southeast Asia to be accredited by the American Society for Gastrointestinal Endoscopy (ASGE).
This year also brought accolades that reflect our commitment to fostering a workplace of innovation and collaboration. Notable honors included Thailand’s Top Corporate Brand Values 2023 from Chulalongkorn University, Thailand’s Best Managed Companies Awards 2024 from Deloitte, and the Outstanding Company Performance Award from the Stock Exchange of Thailand. These recognitions are a testament to our dedication to excellence not only in patient care but also in organizational culture.
Beyond financial success, Bumrungrad remains deeply committed to contributing to society. Our Rak Jai Thai (Healing Hearts) program continues to provide life-saving heart surgeries for underprivileged children with congenital heart disease, while our mobile clinic initiatives deliver essential healthcare to underserved communities. These programs underscore our belief in the importance of giving back and reflect our founding purpose of combining medical excellence with social responsibility.
At the heart of these successes is our extraordinary team. Supported by cutting-edge technology and a shared patient-centric philosophy, our multidisciplinary teams consistently deliver outstanding care to patients worldwide. I extend my heartfelt gratitude to our shareholders, partners, board members, management, doctors, and staff for their unwavering dedication and expertise, which drive Bumrungrad’s achievements.
As we look to the future, we remain vigilant of global challenges, including economic uncertainties and geopolitical tensions. However, with resilience, careful planning, and the shared vision of the Bumrungrad family, we are poised to thrive, expand into new markets, and uphold our mission of redefining global healthcare excellence. Thank you for your trust and support. Together, we will achieve even greater milestones in the years ahead.
Mr. Chai Sophonpanich
Chairman of the Board and Founder of Bumrungrad Hospital Foundation
